From: Oral Complications of Cancer Therapies (PDQ®)
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Indications | Autologous Transplant | Allogeneic Transplant |
---|---|---|
Malignant indications | Multiple myeloma | Acute myeloid leukemia |
Non-Hodgkin lymphoma | Acute lymphoblastic leukemia | |
Hodgkin disease | Chronic myeloid leukemia | |
Neuroblastoma | Myelodysplastic syndromes | |
Ovarian cancer | Myeloproliferative disorders | |
Germ cell tumors | Non-Hodgkin lymphoma | |
Hodgkin disease | ||
Chronic lymphocytic leukemia | ||
Multiple myeloma | ||
Nonmalignant indications | Autoimmune diseases | Aplastic anemia |
Amyloidosis | Paroxysmal nocturnal hemoglobinuria | |
Fanconi anemia | ||
Diamond-Blackfan anemia | ||
Thalassemia major | ||
Sickle cell anemia | ||
Severe combined immunodeficiency | ||
Wiskott-Aldrich syndrome | ||
Inborn errors of metabolism |
aAdapted from Copelan et al.[14].
From: Oral Complications of Cancer Therapies (PDQ®)
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.